iTonic Holdings (ITOC) Liabilities and Shareholders Equity (2023 - 2025)
iTonic Holdings (ITOC) posted Liabilities and Shareholders Equity of $9.1 million for Q4 2025, up 77.85% sequentially from $5.1 million in Q2 2025, and up 35.3% YoY from $6.7 million in Q4 2024.
iTonic Holdings (ITOC) Liabilities and Shareholders Equity (2023 - 2025) Analysis & Trends
iTonic Holdings has reported Liabilities and Shareholders Equity for 3 years, with the latest figure at $9.1 million in Q4 2025.
- Quarterly Liabilities and Shareholders Equity rose 35.3% year-over-year to $9.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $22.6 million (changed N/A YoY) and the FY2025 annual result came in at $9.1 million, up 35.3% from the prior year.
- Liabilities and Shareholders Equity improved to $9.1 million in Q4 2025 per ITOC's latest filing, from $5.1 million in the prior quarter.
- Over five years, Liabilities and Shareholders Equity peaked at $9.1 million in Q4 2025 and troughed at $1.6 million in Q4 2023.
- A 3-year average of $5.6 million and a median of $5.9 million in 2024 frame the typical range for Liabilities and Shareholders Equity.
- The sharpest annual moves came in 2024 and 2025: Liabilities and Shareholders Equity soared 315.88% in 2024, then jumped 35.3% in 2025.
- Over 3 years, Liabilities and Shareholders Equity stood at $1.6 million in 2023, then jumped by 315.88% to $6.7 million in 2024, then jumped by 35.3% to $9.1 million in 2025.
- According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $9.1 million, $5.1 million, and $6.7 million for Q4 2025, Q2 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 109.22 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 47.93 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 93.03 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 45.22 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 13.87 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 6.46 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 37.25 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 31.04 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 10.74 Bn |
| 10 | iTonic Holdings | 4.67 Mn | 1.74 Mn | - | 9.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 9.10 Mn |
| Jun 30, 2025 | 5.11 Mn |
| Dec 31, 2024 | 6.72 Mn |
| Dec 31, 2023 | 1.62 Mn |